
Roche CEO Severin Schwan (Image: Reuters/Arnd Wiegmann)
FTC staff signs off on Roche $4.3B deal for Spark — report
Roche is one step closer to regulatory endorsement — in the form of an FTC staff recommendation — to buy Spark Therapeutics without any asset sales, according …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.